Antimicrobial therapy in theory and practice. II. Clinical approach to antimicrobial therapy.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004751:Enteritis / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007612:Kanamycin / Q000627:therapeutic use; D008034:Lincomycin / Q000627:therapeutic use; D008581:Meningitis / Q000188:drug therapy; D008712:Methicillin / Q000627:therapeutic use; D009268:Nalidixic Acid / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D010033:Otitis Media / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D010612:Pharyngitis / Q000188:drug therapy; D011015:Pneumonia, Aspiration / Q000188:drug therapy; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D010406:Penicillins; D009268:Nalidixic Acid; D007612:Kanamycin; D004917:Erythromycin; D000667:Ampicillin; D008034:Lincomycin; D009355:Neomycin; D008712:Methicillin